摘要 |
Described are piperlines of Formula (I) and pharmaceutically acceptable salt s thereof. The compounds of Formula (I) ar antagonists of NMDA receptor channe l complexes useful for treating cerebral vascular disorders such as, for example, stroke, cerebral ischemia, central nervous system disorders, depression, trauma, hypoglycemia, neurodegenerative disorders, anxiety, migraine headache, convulsions, Parkinson's disease, aminoglycoside antibiotics-induced hearing loss, psychosis, glaucoma, CMV retitins, opioid tolerance or withdrawal, pain, especially chronic pain, neuropathic pain, or surgical pain, or urinary incontinence.
|
申请人 |
WARNER-LAMBERT COMPANY LLC |
发明人 |
KORNBERG, BRIAN EDWARD;LEWTHWAITE, RUSSELL ANDREW;MANNING, DAVID DOUGLAS;NIKAM, SHAM SHRIDHAR;SCOTT, IAN LESLIE |